Andrew J. Einhorn Rvl Pharmaceuticals PLC (RVLP) insider trading activity

RVLP Quotes by TradingView

Andrew J. Einhorn is Chief Financial Officer of RVL Pharmaceuticals plc. Currently has a direct ownership of 141,473 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2022, when has been sold 9,607 shares (Ordinary Shares) at a price of $1.13 per share, resulting in proceeds of $10,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K
0% 3M change
0% 12M change
Total Value Held $0

Andrew J. Einhorn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2022
SELL
Payment of exercise price or tax liability
$10,856 $1.13 p/Share
9,607 Reduced 6.36%
141,473 Ordinary Shares
May 18 2021
SELL
Payment of exercise price or tax liability
$20,177 $3.12 p/Share
6,467 Reduced 4.1%
151,080 Ordinary Shares
Jan 24 2021
SELL
Payment of exercise price or tax liability
$43,119 $4.46 p/Share
9,668 Reduced 5.78%
157,547 Ordinary Shares
AJE

Andrew J. Einhorn

Chief Financial Officer
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVLP